Form D · Pharmaceuticals

Hydropothecary Corp

Gatineau, A8 · CIK 0001690947

Offering snapshot reported Nov 29, 2016 · SEC filing

Reported sold
$3.28M
Offering amount: $10.2M
Investors reported
24
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 14, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.64M$3.28MNov 29, 2016: $3,275,000.00Nov 29, 2016Nov 29, 2016: $3,275,000.00Nov 29, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2016Initial$3,275,000No comparison24SEC filing
Nov 29, 2016Amendment$3,275,000$0vs Nov 29, 201624SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$289K
Finders' fees
$0
Form D file number
021-275268
Axiom Capital Management, Inc. was paid a commission/placement agents fee of US$289,013 and 62,381 agents common share purchase warrants, each exercisable to acquire one common share at a price of US$4.60 per share for a period of three years.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
AXIOM CAPITAL MANAGEMENT, INC.26580

Source: Form D, filed Nov 29, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ed Chaplin Executive
Vincent Chiara Director
Jason Ewart Director
Adam Gaston Miron Director, Executive
Michael Munzar Director
Sebastien Georges St. Louis Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
120 Chemin De La Rive
Gatineau, A8, J8M 1V2